Osisko Reports Q2 2024 Results
August 06, 2024 17:43 ET
|
Osisko Gold Royalties Ltd.
Record operating cash flows of $52.3 million with quarterly cash margin of 97% Appointment of Ms. Wendy Louie to the Board of Directors MONTREAL, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Osisko...
Firm Capital Property Trust Reports Q2/2024 Results
August 06, 2024 17:27 ET
|
Firm Capital Property Trust
STRONG SEQUENTIAL SAME-STORE NOI AND NAV GROWTH DECLINING AFFO PAYOUT RATIO TORONTO, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Firm Capital Property Trust (“FCPT” or the “Trust”), (TSX: FCD.UN) is...
Rapid7 Announces Second Quarter 2024 Financial Results
August 06, 2024 16:05 ET
|
Rapid7
Rapid7 Announces Second Quarter 2024 Financial Results
BioRestorative Therapies to Report Second Quarter 2024 Financial Results and Host Conference Call on August 13, 2024
August 06, 2024 16:05 ET
|
BioRestorative Therapies, Inc
MELVILLE, N.Y., Aug. 06, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage company focused on stem cell-based...
Healthier Choices Management Corp. Reports Second Quarter 2024 Financial Results
August 06, 2024 08:30 ET
|
Healthier Choices Management Corp
Sales of $15.6 million for the Second Quarter; $2.0 million Year-Over-Year Growth Gross Margin of $5.9 million for the Second Quarter; $0.8 million Year-Over-Year Growth ...
AC Immune Reports Second Quarter 2024 Financial Results and Provides a Corporate Update
August 06, 2024 07:00 ET
|
AC Immune SA
AC Immune Reports Second Quarter 2024 Financial Results and Provides a Corporate Update Announced exclusive option and license agreement with Takeda for ACI-24.060 on May 13 for $100 million upfront...
Longeveron® to Report Second Quarter 2024 Financial Results and Host Conference Call on August 14, 2024
August 05, 2024 16:05 ET
|
Longeveron
Longeveron announced that it will report Q2 2024 financial results and provide a business update on Wednesday, August 14, 2024.
CSX Corp. Announces Second Quarter 2024 Results
August 05, 2024 16:01 ET
|
CSX Corporation
JACKSONVILLE, Fla., Aug. 05, 2024 (GLOBE NEWSWIRE) -- CSX Corp. (NASDAQ: CSX) today announced second quarter 2024 operating income of $1.45 billion compared to $1.47 billion in the prior year...
BioNTech veröffentlicht Ergebnisse für das zweite Quartal 2024 sowie Informationen zur Geschäftsentwicklung
August 05, 2024 05:59 ET
|
BioNTech SE
Veröffentlichung positiver Daten aus mehreren klinischen Studien mit mRNA-Krebsimpfstoffen, einschließlich erster Ergebnisse aus der laufenden Phase-2-Studie zur Evaluierung des FixVac-Kandidaten...
BioNTech Announces Second Quarter 2024 Financial Results and Corporate Update
August 05, 2024 05:59 ET
|
BioNTech SE
Announced positive data from multiple mRNA cancer vaccine clinical trials, including topline results from the ongoing Phase 2 evaluating FixVac candidate BNT111Launched updated variant-adapted...